The FDA’s Process Analytical Technology PAT initiative was put forth to bring pharmaceutical manufacturing in line with other automated industries. Traditionally, pharma companies have been hesitant to implement innovative technology for performing quality analysis in the manufacturing process. The FDA has recognized it may be part of this problem and as a result has put forth the PAT initiative. The goal being to ease pharma manufacturer’s fears about drawing regulatory scrutiny for using innovative approaches in the development, manufacture, and quality assurance of new and existing products.

Address: Novinity Software, 274 Discovery Drive, Bozeman, Montana 59718
Telephone: (206) 347-1020
Fax: (406)587-9725
Website: http://pattoolkit.com/